Sanofi, GSK to supply up to 60 million doses of COVID-19 vaccine to UK

Sanofi, GSK to supply up to 60 million doses of COVID-19 vaccine to UK
Sanofi, GSK to supply up to 60 million doses of COVID-19 vaccine to UK Financial terms of the agreement were not disclosed. Sanofi and GSK, which had first teamed up in April, confirmed in a statement that regulatory approval for their vaccine could be achieved by the first half of 2021 if clinical data was to be positive.